The Society for Immunotherapy of Cancer (SITC) is convening key oncology experts from academia, industry and government, including the FDA and NCI, to lead a national conversation around what’s become a crisis in clinical research. The crisis is the result of a multitude of factors including clinical trial administrative staffing shortages, administrative burdens, and current business models.Through discussions with key stakeholders in academia, industry, and government, it has become apparent that this crisis is having a significant negative impact on cancer drug development and patient care, which threatens advancement of the field for years to come. Leveraging its convening powers, SITC is leading the national conversation around this crisis and is committed to finding collaborative solutions that ultimately reduce the administrative burden of clinical trials while increasing patient access to safe and effective clinical trials.
Aug. 17, 2022 • 10 a.m.–3:30 p.m. ET • Free Virtual Program • #SITCresearchsolutions
Registration is closed. Thank you for attending. RECORDING & PANELISTS An initial step in addressing the crisis in clinical research is to host a multi-stakeholder virtual summit with oncologists, administrators, the NCI, the FDA, pharmaceutical companies, contract research organizations, and other major oncology professional organizations. The summit will further delineate the current staffing and administrative issues for oncology clinical trials, as well as consider alternative clinical trials administrative models to reduce the current burden.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com